Latest Headlines

Latest Headlines

J&J helps bankroll a $55M gamble on partner Aduro's PhIIb cancer drug study

With the ink still drying on a $365 million deal to in-license rights to a therapeutic cancer vaccine and immunotherapy tech at Aduro BioTech, J&J is back with the news that it is also helping to bankroll the company's research work, jumping into a syndicate which has pledged $55 million to fuel an advanced drug study.

AstraZeneca extends global shopping spree with $232M asthma drug deal

AstraZeneca's executive crew extended one of the biggest shopping sprees in the industry with a pact, in-licensing rights to a drug from Synairgen that targets the viral infections that afflict the respiratory tracts of asthma patients. And the little biotech's shares soared on the news.

AbbVie to co-promote hep C diagnostic

AbbVie will have exclusive promotion rights to the sole FDA-approved point-of-care test for the hepatitis C virus, under a co-promotion agreement with OraSure Technologies, maker of the OraQuick HCV Rapid Test.

CROs unite to kick-start a biotech's pipeline

Four pharma service providers, led by MPI Research, have joined forces to form KPI Therapeutics, a new biotech designed to develop promising drug candidates and speed their way to market.

InVentiv signs on to market 3-D printed drugs

Aprecia has an MIT-licensed method of 3-D printing pills and a plan to hit the market with easy-to-take formulations of top-selling medicines. To get there, the biotech has tapped CRO inVentiv Health, which is on hand to lend its commercialization expertise.

Bristol-Myers deepens its ties to Biocon's CRO and Indian R&D

As many drugmakers scale down their R&D presences in India, Bristol-Myers Squibb is strengthening its relationship with Syngene, the CRO arm of local giant Biocon.

London's Institute of Cancer Research to help develop MRI-guided radiation systems

The Institute of Cancer Research, London, became the latest member of a consortium seeking to integrate magnetic resonance imaging into radiation therapy. 

Roche and MedImmune will concoct lung cancer immunotherapy clinical trial test

Roche's Ventana Medical Systems and MedImmune said they will jointly develop an assay to help test a MedImmune immunotherapy for non-small cell lung cancer.

Shire sweetens its arGEN-X deal with a $20M investment

Deepening its ties with Dutch antibody specialist arGEN-X, Shire has expanded the scope of the pair's R&D agreement and kicked in some cash to get the ball rolling.

Med tech incubator to assist Silicon Valley startups

A team of biomedical engineers, venture capitalists and device businesspeople are launching a new incubator for med tech startups in Silicon Valley.